Solesence (SLSN) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$55.4M

Revenue (quarter)

$15.3M

Revenue growth (year over year)

−24.69%

Gross profit (trailing twelve months)

$13.9M

Gross margin

25.04%

Net income (trailing twelve months)

−$2.9M

Net income (quarter)

−$158,000.00

Net income growth (year over year)

−104.89%

Net margin

−5.25%

Return on equity

−18.55%

EPS (trailing twelve months)

−$0.04

Book value per share

$0.19

P/E (trailing twelve months)

—

Price to book

5.32

Debt to assets

71.67%

Payout ratio

—

Dividend yield

—

Company profile

Solesence Inc is a health-oriented, science-driven company, focused on various skin health, beauty and wellness markets. Its primary skin health products are fully developed prestige skin care formulations with mineral-based UV protection enabled by proprietary Active Pharmaceutical Ingredients, which are also marketed as APIs for sale to manufacturers of other types of skin health products, including sunscreens and daily care products. Additionally, it continues to sell products in legacy markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. The company operates as a single business segment.

• Is Solesence (SLSN) profitable?

  No. Solesence reported a net loss of $2.9M over the trailing twelve months.

• How much revenue does Solesence (SLSN) make?

  Solesence generated $55.4M in revenue over the trailing twelve months, down 24.69% year over year.

• How do I buy stock in Solesence (SLSN)?

  SLSN trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.